298 related articles for article (PubMed ID: 23580576)
21. Menin and PRMT5 suppress GLP1 receptor transcript and PKA-mediated phosphorylation of FOXO1 and CREB.
Muhammad AB; Xing B; Liu C; Naji A; Ma X; Simmons RA; Hua X
Am J Physiol Endocrinol Metab; 2017 Aug; 313(2):E148-E166. PubMed ID: 28270438
[TBL] [Abstract][Full Text] [Related]
22. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
23. The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.
Dreijerink KM; Varier RA; van Beekum O; Jeninga EH; Höppener JW; Lips CJ; Kummer JA; Kalkhoven E; Timmers HT
Mol Cell Biol; 2009 Sep; 29(18):5060-9. PubMed ID: 19596783
[TBL] [Abstract][Full Text] [Related]
24. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
Thakker RV
Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
[TBL] [Abstract][Full Text] [Related]
25. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
[TBL] [Abstract][Full Text] [Related]
26. The role of tumor suppressor menin in IL-6 regulation in mouse islet tumor cells.
Song TY; Lim J; Kim B; Han JW; Youn HD; Cho EJ
Biochem Biophys Res Commun; 2014 Aug; 451(2):308-13. PubMed ID: 25088994
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
28. Regulation of cyclin B2 expression and cell cycle G2/m transition by menin.
Wu T; Zhang X; Huang X; Yang Y; Hua X
J Biol Chem; 2010 Jun; 285(24):18291-300. PubMed ID: 20404349
[TBL] [Abstract][Full Text] [Related]
29. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.
Chen YX; Yan J; Keeshan K; Tubbs AT; Wang H; Silva A; Brown EJ; Hess JL; Pear WS; Hua X
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1018-23. PubMed ID: 16415155
[TBL] [Abstract][Full Text] [Related]
31. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
32. Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.
Gao SB; Feng ZJ; Xu B; Wu Y; Yin P; Yang Y; Hua X; Jin GH
Oncogene; 2009 Nov; 28(46):4095-104. PubMed ID: 19749796
[TBL] [Abstract][Full Text] [Related]
33. Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas.
Bonnavion R; Teinturier R; Gherardi S; Leteurtre E; Yu R; Cordier-Bussat M; Du R; Pattou F; Vantyghem MC; Bertolino P; Lu J; Zhang CX
J Pathol; 2017 May; 242(1):90-101. PubMed ID: 28188614
[TBL] [Abstract][Full Text] [Related]
34. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
Milne TA; Hughes CM; Lloyd R; Yang Z; Rozenblatt-Rosen O; Dou Y; Schnepp RW; Krankel C; Livolsi VA; Gibbs D; Hua X; Roeder RG; Meyerson M; Hess JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):749-54. PubMed ID: 15640349
[TBL] [Abstract][Full Text] [Related]
35. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.
Yuan Z; Sánchez Claros C; Suzuki M; Maggi EC; Kaner JD; Kinstlinger N; Gorecka J; Quinn TJ; Geha R; Corn A; Pastoriza J; Jing Q; Adem A; Wu H; Alemu G; Du YC; Zheng D; Greally JM; Libutti SK
Oncotarget; 2016 Mar; 7(11):12633-50. PubMed ID: 26871472
[TBL] [Abstract][Full Text] [Related]
36. Functional studies of menin through genetic manipulation of the Men1 homolog in mice.
Balasubramanian D; Scacheri PC
Adv Exp Med Biol; 2009; 668():105-15. PubMed ID: 20175458
[TBL] [Abstract][Full Text] [Related]
37. Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response.
Busygina V; Kottemann MC; Scott KL; Plon SE; Bale AE
Cancer Res; 2006 Sep; 66(17):8397-403. PubMed ID: 16951149
[TBL] [Abstract][Full Text] [Related]
38. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells.
Sayo Y; Murao K; Imachi H; Cao WM; Sato M; Dobashi H; Wong NC; Ishida T
Endocrinology; 2002 Jun; 143(6):2437-40. PubMed ID: 12021209
[TBL] [Abstract][Full Text] [Related]
39. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M
Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714
[TBL] [Abstract][Full Text] [Related]
40. Clinically Defined Mutations in
Duan S; Sheriff S; Elvis-Offiah UB; Witten BL; Sawyer TW; Sundaresan S; Cierpicki T; Grembecka J; Merchant JL
Cancer Res Commun; 2023 Jul; 3(7):1318-1334. PubMed ID: 37492626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
